Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02218385 · ClinicalTrials.gov registry record
ForeCYTE Breast Aspirator for Sample Collection and Cytological Testing of Nipple Aspirate Fluid
A clinical trial, sponsored by Atossa Therapeutics.
- Completed
- Registry status
- 52
- Enrollment target
NCT02218385 is a clinical trial that has completed, run by Atossa Therapeutics. The registered enrollment target is 52 participants.
The verdict
NCT02218385 has completed, sponsored by Atossa Therapeutics.
- COMPLETED
- Registry status
- 52 participants
- Enrollment target
Study Summary
The purpose of this study is to measure the performance characteristics for the collection, fixation and transportation of clinical nipple aspirate fluid (NAF) specimens of the ForeCYTE Breast Aspirator across 3 independent labs and the National Reference Laboratory for Breast Health (NRLBH). The study hypothesis is that each lab will have a specimen acceptability rate of at least 90%. If it is assumed that the true level of acceptability testing is approximately 96%, then the lower bound of a one-sided 95% confidence interval is expected to be at least 90%.
Interventions
- DEVICE ForeCYTE Breast Aspirator
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2014-08 |
| Est. Completion | 2014-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02218385
The ClinicalTrials.gov registry entry for NCT02218385 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Atossa Therapeutics, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ForeCYTE Breast Aspirator is the first listed.
NCT02218385 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02218385 about?
NCT02218385 is a clinical study titled "ForeCYTE Breast Aspirator for Sample Collection and Cytological Testing of Nipple Aspirate Fluid". The purpose of this study is to measure the performance characteristics for the collection, fixation and transportation of clinical nipple aspirate fluid (NAF) specimens of the ForeCYTE Breast Aspirator across 3 independent labs and the National Reference Laboratory for Breast Health (NRLBH). The st...
What is the current status of trial NCT02218385?
This trial is currently completed. The enrollment target is 52 participants. The study started on 2014-08. Estimated completion is 2014-08.
What interventions are being tested in trial NCT02218385?
The interventions under investigation include: ForeCYTE Breast Aspirator (DEVICE).
Who is sponsoring clinical trial NCT02218385?
This trial is sponsored by Atossa Therapeutics, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.